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The purpose of this paper is to compare and contrast the discrete biology diﬀerentiating fetal wound repair from its adult
counterpart. Integumentary wound healing in mammalian fetuses is essentially diﬀerent from wound healing in adult skin. Adult
(postnatal)skinwoundhealingisacomplexandwell-orchestratedprocessspurredbyattendantinﬂammationthatleadstowound
closure with scar formation. In contrast, fetal wound repair occurs with minimal inﬂammation, faster re-epithelialization, and
without the accumulation of scar. Although research into scarless healing began decades ago, the critical molecular mechanisms
driving the process of regenerative fetal healing remain uncertain. Understanding the molecular and cellular events during
regenerative healing may provide clues that one day enable us to modulate adult wound healing and consequently reduce scarring.
1.Introduction
In adult (postnatal) mammalian organisms, injury to cuta-
neous tissue with disruption of normal skin architecture
is repaired by means of an inﬂammatory and ﬁbrotic
response that leads to accumulation of scar [1]. Although
scar formation allows for the rapid sealing of an injured area,
it can frequently prove the source of persistent pathology
in the organism. For example, scar formation after ten-
don repair will limit their gliding ability, restricting hand
function; intra-abdominal scar/adhesions frequently lead to
small bowel obstruction, necessitating surgical intervention;
cirrhosis of the liver and pulmonary ﬁbrosis are also forms of
excessive scarring.
Nowhere, however, is scar more evident or problematic
than in the skin. Cicatrix in the extremities and digits can
causecontractureandrestrictmotion,resultinginsigniﬁcant
disability. Scar in the genitalia can interfere with sexual
function and even urination. Scar formation in the facial
skin of the head and neck is particularly problematic, with
multiple vital functions at risk. Scar in the external ear
can cause substantial hearing loss, and constriction of the
nasal apertures can interfere with respiration, smell, and
derivatively, taste. Scar contractures following burn injury
are well known to progress to microstomia, nasal stenosis,
lip or eyelid ectropion if severe enough. They can lead
to restriction of neck movement and permanent mouth
opening [2–4]. If left untreated in a growing child, such
severe contractures can even lead to secondary facial skeletal
abnormalities, compounding the problem [5]. In addition
to the functional deﬁcits facial scar can inﬂict, there is
also the obvious social opprobrium of visible disﬁgurement.
Scar, then, represents a signiﬁcant source of morbidity, and
can frequently require aggressive measures to deal with its
sequelae [6].
In contrast to adults, fetal integumentary wounds in
humans and other mammals heal rapidly without associated
scarring until late in gestation [7–9]. Investigation into the
phenomenon of fetal wound healing started in the early
1950s with the study of animal models, which showed
that fetal skin wounds could heal rapidly but without any
apparent “dediﬀerentiation” of cellular components such2 Dermatology Research and Practice
as occurred in regenerating amphibians [10]. Later, exam-
ination by Rowlatt [11] of healing limbs after intrauterine
amputation by amniotic constriction bands in a 20-week
old human fetus showed that human skin at this stage
of development healed without apparent inﬂammation.
Subsequent work has conﬁrmed that fetal wounds heal
diﬀerently depending on the gestational age of the fetus,
including even in the pouch young of a marsupial [12].
In general, the scarless character of fetal wound repair
persists until roughly the middle of the third trimester of
intrauterine gestation, at which point a transition to the
adult, scar-forming pattern of wound repair occurs [13–
15]. This scarless healing is a property intrinsic to fetal
tissues, and not a conferred beneﬁt of the protected uterine
environment: fetal skin placed subcutaneously into athymic
mice and then wounded still heals without scar, in spite of
occurring in an environment free of amniotic ﬂuid [16].
Conversely, adult skin grafted onto immunoprivileged fetal
hosts in utero and then wounded still heals with scar [17].
Because early- to mid-gestational fetal wound healing
occurs with evident restoration of normal skin architecture
and no signiﬁcant scar deposition, it has been termed
“regenerative,” and has been taken as a model by which
we may attempt to engineer the same process in adults. It
therefore becomes important to understand at the cellular
and molecular level the distinctions between these two
physiologies, in the hopes that an understanding of fetal
biology may one day enable its recapitulation in the adult.
2. The Biology of Adult Wound Healing
2.1. Inﬂammatory Phase. The process of skin wound repair
in adult mammalian organisms is an intricate and highly
coordinated process that generally can be divided into four
overlapping phases: hemostasis, inﬂammation, proliferation,
andremodeling[18].Anyinjurythatseversbloodvesselswill
trigger events that try to eﬀect immediate hemostasis. This
process includes vasoconstriction, platelet aggregation, and
platelet α-degranulation of vesicles containing both clotting
and growth factors. Platelets are also believed to play an
additional role in the wound healing cascade, not only as
initiators of coagulation but also through the release of a
multitude of growth factors and cytokines that modulate
ﬁbroblast activity, such as transforming growth factor β1
(TGF-β1) and platelet-derived growth factor (PDGF) [19].
These growth factors provide a chemotactic stimulus for
neutrophils, ﬁbroblasts, and monocytes and ultimately aﬀect
the dynamics of extracellular matrix (ECM) synthesis [20,
21]. Neutrophils are early responders to these chemotactic
agents and begin to inﬁltrate to the site of injury well before
the activation and/or arrival of ﬁbroblasts and monocytes.
They accomplish phagocytosis of bacteria and functional
debridement of injured tissue while themselves secreting
additional proinﬂammatory cytokines. In the presence of
foreign body or infection, a persistent neutrophil-rich
inﬂammatoryresponseresultswhichcanleadtopoorwound
healing and excess ﬁbrosis [22].
Monocytes are also attracted to the wound site in
response to a variety of chemoattractants derived from intra-
and extravascular sources. Monocytes become macrophages,
which are considered the principle coordinators of adult
wound healing [23]. Macrophages act as avid phagocytes,
ingesting debris in the wound ﬁeld (including even spent
neutrophils), and they also produce numerous cytokines
and growth factors crucial for ﬁbroblast recruitment and
angiogenesis. Monocytes and activated macrophages are
known to bind to the ECM through cell surface integrin
receptors; this adherence to the ECM induces ECM phago-
cytosis, promoting wound debridement. Attachment to the
ECM also alters the gene expression proﬁle of macrophages,
leading to increased expression and subsequent secretion of
colony stimulating factor 1 (CSF-1, required for macrophage
survival), tumor necrosis factor (TNF-α, inﬂammatory
cytokine), and PDGF (chemotactic agent for ﬁbroblasts)
[24, 25]. As in the case of an extended neutrophilic inﬁltrate,
apersistentmacrophageresponsemayalsoleadtoexcessscar
formation, itself an unwanted outcome [26].
Another key leukocyte lineage, the mast cell (MC),
derived from circulating basophils, is postulated to con-
tribute to the healing of skin wounds, and MC’s have been
implicated in multiple phases of wound healing [27, 28].
Egozi et al. [29] showed using MC-deﬁcient KitW/KitW−v
mice that neutrophil inﬁltration was reduced at early time
points (inﬂammatory phase) but that the absence of mast
cells had no eﬀect on the proliferative aspects of wound heal-
ing. Weller et al. [30] showed using the same MC-deﬁcient
KitW/KitW−v mice that MC activation and histamine release
are required for proper recruitment of neutrophils and also
for the normal closure of wounds. Ultimately, ﬁbroblasts
enter the wound site and replace the initial wound ﬁbrin
matrix by depositing glycosaminoglycans, proteoglycans,
and other ECM proteins such as ﬁbronectin and tenascin.
This last is another example of the complicated interplay
of multiple factors in cutaneous wound healing and scar
formation, since ﬁbronectin promotes cellular adhesion
to the underlying substratum, whereas tenascin actually
facilitates ﬁbroblast migration by antagonizing ﬁbronectin
[31, 32].
Interestingly, although inﬂammatory cells are intimately
involved in the regulation and progression of normal adult
wound healing, several lines of evidence suggest that deple-
tion of one or more of the inﬂammatory cell types can actu-
allyhaveapositiveoutcomeontheclosureofwounds.Exper-
imentsconductedbySzpaderskaetal.[33]demonstratethat,
as long as bleeding is adequately controlled, mice dosed with
antiplatelet antisera to induce thrombocytopenia show no
deﬁcit in the proliferative aspects of repair, including wound
closure, angiogenesis, and collagen synthesis, all of which
were unaﬀected compared to controls. This data suggests
that platelets are not absolutely essential for normal adult
wound healing to occur. Similar experiments in neutrophil-
depleted mice [34] showed that wound closure was actually
more rapid in the mice with induced neutropenia than in
control animals, suggesting that neutrophils, while perhaps
highly utile in combating infection, may in other respects
actually be inhibitory to wound healing. Neonatal PU.1-
knockout mice (which lack macrophages and functioning
neutrophils) healed wounds with minimal scarring, with anDermatology Research and Practice 3
altered growth factor and cytokine proﬁle at the wound site,
reduced cell death, and with phagocytic ﬁbroblasts standing
informoreconventionalinﬂammatorycells[35].Ittherefore
appears that macrophages too are not absolutely required for
normal adult wound repair, and their absence may actually
allow a more scarless mode of healing.
2.2. Proliferative Phase. The formation of granulation tissue,
a well-vascularized connective tissue containing macro-
phages and ﬁbroblasts that replaces ﬁbrin clot, is a notable
feature of the proliferative phase of adult wound healing.
This granulation tissue has been considered to be a con-
tractile organ, responsible for the active wound contraction
seen in the proliferative phase of adult wound healing, a
contractionaﬀectedchieﬂybyﬁbroblastsandtheirderivative
subtypes,myoﬁbroblasts(seebelow).Therateofgranulation
tissue formation appears to be dependent on interaction of
the ﬁbroblast integrin receptor with ﬁbronectin [36]. The
initial ﬁbrin clot functions as a chemokine to stimulate
macrophages and ﬁbroblasts to migrate into the wound
space; in the case of the latter, this migration itself is
thought to apply traction to the wound periphery, assisting
in its contraction and ultimate closure. Within the wound
bed macrophages provide a continuing source of growth
factors necessary for angiogenesis [37], and ﬁbroblasts lay
down a provisional matrix mainly composed of collagen and
proteoglycans.
Multiple studies have pointed to a particularly important
role for transforming growth factor- beta in this phase
of wound healing. Expression of the TGF-β1a n dT G F - β2
isoforms (in comparison to TGF-β3) is increased in adult
wounds, and studies show that exogenous administration of
TGF-β1a n dT G F - β2 to healing wounds results in increased
collagen, protein, and inﬂammatory cell accumulation [38].
In contrast, Ferguson et al. (2009) [39] assessed scar quality
after treatment with avotermin (recombinant human TGF-
β3) in Phase II clinical trials in humans, and showed that
avotermin has the potential to provide an improvement in
the appearance of scars. As repair progresses, ﬁbroblasts also
displayincreasedexpressionlevelsofadhesionmoleculesand
assumeacontractilemyoﬁbroblastphenotypewithincreased
alpha-smooth muscle actin (α-SMA) expression, known to
be stimulated by TGF-β1a n dT G F - β2a sw e l la sb yP D G F
[40, 41]. Wound ﬁbroblasts and myoﬁbroblasts work in
concert to draw the wound closed and also contribute to the
synthesis and alignment of collagen ﬁbers [42].
The formation of granulation tissue in an open wound
also allows the process of re-epithelialization to begin, as
epithelial cells migrate across the new tissue to form a
barrier between the wound and the environment. Intracel-
lular actin microﬁlaments are formed, and alterations in
intermediate ﬁlament gene and protein regulation have also
been observed, [43] enabling the epidermal cells to creep
across the wound surface. Multiple growth factors, including
epidermal growth factor (EGF), keratinocyte growth factor
(KGF), transforming growth factor-alpha (TGF-α), and
epiregulin are thought to act synergistically to stimulate re-
epithelialization [44–46].
2.3. Remodeling Phase. In the remodeling phase, which can
last for up to a year after injury, there is ongoing synthesis,
degradation, cross-linking, and reorientation of collagen to
form the mature scar. The healing and remodeling tissue will
manifest increasing tensile strength, however, the resultant
scar will never attain physical properties equal to that of the
uninjured tissue [47]. Remodeling allows for some removal
of accumulated connective tissue and is made possible by
matrix metalloproteinases (MMPs) under the control of a
cytokine network [48]. The coordinated regulation of these
enzymes and their inhibitors ensures tight control of local
proteolytic activity.
Over time the quantity of ﬁbroblasts and myoﬁbroblasts
within the maturing wound bed are reduced by apoptosis,
which may be precipitated by the withdrawal of cytokines
as the wound heals, although the precise mechanisms
governingthisresponseremainunclear[49].Withcontinued
remodeling the outgrowth of capillaries is halted, blood ﬂow
to the area is reduced and metabolic activity in the area
declines with the maturation of a relatively hypocellular and
hypovascular scar.
3. Disordersof ExcessiveCutaneousFibrosis
While the above summarizes many of the important features
of normal adult wound healing, there also exist conditions
marked by an abnormal pathological response to cutaneous
wound healing resulting in excessive ﬁbrosis, the two main
examples of which are hypertrophic scars and keloids.
Hypertrophic scars typically take the form of a reddish raised
lump on the skin; they remain within the boundaries of
the original zone of injury and often naturally improve in
appearance after some years [50, 51]. They are frequently
amenable to surgical revision, with the expectation that the
revision will obtain a more favorable result. In contrast
keloidal scars will typically progress into large, tumorous
(although benign) masses that clearly exceed the original
zone of injury. Keloids are not known to regress spon-
taneously and their recurrence rate is high after surgical
excision [51], even with the use of such adjunctive measures
as local corticosteroid injection or pressure appliances. Both
hypertrophic scars and keloids represent a type of abnormal
ﬁbroproliferative wound repair, and it appears that several
stages of wound healing, from the inﬂammatory phase to the
remodeling phase, are signiﬁcantly altered [52, 53].
Gene proﬁling studies have identiﬁed previously unsus-
pected genes of potential relevance to the pathogenesis of
hypertrophic scars and keloids. cDNA microarray examina-
tion of tissue mRNA obtained from burn hypertrophic scars
(compared to normal skin) revealed that genes displaying
altered expression included proto-oncogenes, genes involved
with apoptosis, immune regulatory genes, cytoskeletal ele-
ments, and transcription factors, signifying that multiple
pathways are involved in hypertrophic scar formation and
contraction [54]. Similar microarray studies examining
altered gene expression in keloids and in ﬁbroblasts derived
from keloid lesions identiﬁed genes which have previously
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identiﬁed multiple genes not previously suspected to play a
role in keloid formation. Naitoh et al. [55]o b s e rv e ds t r o n g e r
ectopic expression (in keloids) of chondrocyte/osteoblast
marker genes, namely, periostin, OB-cadherin, lumican, and
mimecan as well as increased expression of transcription
factorsSOX9andCBFA1,knowntobeinvolvedinregulation
of the above-mentioned gene products. The same study also
marked upregulation of two tumorigenesis- related genes,
p311 and ﬁbroblast activation protein alpha (FAP-α). Satish
et al. [56] also showed the upregulation of tumor-related
genes in keloid ﬁbroblasts, namely, TCTP (tumor protein
translationally controlled 1), MORF-related gene 15 (MRF
15),annexin2,andribosomalproteinsRPS18,10,andL23A.
This interesting increase in genes related to tumorigenesis is
congruent with the behavior of keloidal ﬁbroblasts, which
proliferate in a rapid and unregulated manner and invade
normal skin tissues, beyond the boundaries of the initial
region of injury.
4.Characteristicsof FetalSkin
In order to understand the basis of regenerative fetal skin
healing, and to contrast it to the adult tissue repair described
above, it is helpful to ﬁrst recognize the pattern of devel-
opment of fetal skin. In humans, prior to the 24th week of
gestation, fetal skin tissue is less diﬀerentiated than adult
skin [15]. The human fetal integument begins with two
cell layers, the basal cell layer and the periderm, at about 4
weeks gestation. The periderm is the outermost single-cell
layer of the fetal skin; although the function of the periderm
has not been determined, a secretory or absorptive process
has been hypothesized [14]. As development continues, an
intermediate epidermal cell layer develops. Keratinization
begins at 9 to 10 weeks gestation, and during this period hair
follicles and sebaceous glands become apparent. By 24 weeks
gestation, that is, toward the end of the second trimester,
at which time fetal skin wounds continue to demonstrate
scarless healing, the epidermis has completely keratinized
and stratiﬁed into adult morphologic layers [57].
Fetal skin contains ﬁbroblasts and fetal extracellular
matrix (ECM) that are distinct from adult ﬁbroblasts and
adult ECM. Fetal dermis thickens by increasing collagen
content and replacing nonsulfated glycosaminoglycans with
sulfated glycosaminoglycans. Fetal ECM contains higher
proportions of type III collagen, chondroitin sulfate, pro-
teoglycan, and hyaluronic acid than does adult ECM [15].
Coolen et al. [58] have recently examined multiple dermal
and epidermal components of human fetal and adult skin,
ﬁnding that most diﬀerences between these tissue types
reside at the level of dermal ECM molecular expression. For
example, elastin was present in adult dermis, but was not
detected in fetal dermis. Conversely, chondroitin sulfate and
ﬁbronectin both were expressed at substantially higher levels
in fetal dermis compared to adult. The expression patterns
of basement membrane proteins, keratin isoforms (e.g.,
K10, K14, K16) and epidermal Ki-67 were not signiﬁcantly
diﬀerent between fetal skin and adult skin biopsies.
MMPs and tissue inhibitors of the proteolytic activity of
MMPs (TIMPs), molecules that regulate ECM turnover, are
also shown to be diﬀerentially regulated as fetal skin devel-
ops. Dang et al. [59] found that baseline expression of MMPs
1,2,and14allincreasedwiththetransitiontoascarringphe-
notypeinfetalratskin,withMMP2messagelevelsincreasing
by 50-fold. Nonetheless, they determined that E16 (scarlessly
healing) wounds had a higher MMP to TIMP expression
ratio than E19 scarring wounds. Other ECM molecules
diﬀerentially expressed in developing fetal skin and wounds
include decorin, a proteoglycan implicated in regulation of
TGF-β bioactivity, which has been shown to increase during
the ontogenic transition from scarless fetal healing to adult
wound healing, but which is actually decreased by wounding
during the scarless healing period [60]. In contrast, ﬁbro-
modulin, another small interstitial proteoglycan which can
bind to and modulate TGF-β activity, has been shown to
decrease with advancing gestational age, and decreases as
well when adult skin is wounded, but is actually increased in
scarlessly healing fetal wounds relative to control [61]. These
observations give some indication of the complicated and
mixed functions ECM molecules may play in determining
the scarless nature of early fetal wound repair.
5. The Biology of Fetal Wound Healing
Healing cutaneous wounds in mammalian fetuses shows
multiple important diﬀerences from adult healing; many of
theseareenumeratedinTable 1. Perhapsthe mostsigniﬁcant
characteristic feature of scarless fetal wound healing that
stands in contradistinction to adult is a signiﬁcantly reduced
inﬂammatory response [62]. A markedly diminished or
minimal inﬂammatory response in fetal wounds has been
demonstrated in multiple fetal animal models [62–65]. The
absence of an acute inﬂammatory inﬁltrate in fetal wounds
may partly be explained by decreased platelet aggregation
and degranulation in fetal tissues; fetal platelets are also
thought to release lower levels of cytokines, thereby also
potentially reducing the recruitment of inﬂammatory cellsto
fetalwounds[66].Hopkinson-Woolleyetal.[67],examining
embryonic and fetal mice, have found that macrophages
are not normally recruited to fetal wound sites before
developmental stage E14.5, but that after this transition stage
therewasasigniﬁcantrecruitmentofmacrophageswithin12
hours of injury. Furthermore, few neutrophils are present in
the fetal wound, and an age-dependent defect in the ability
of fetal neutrophils to phagocytose pathogenic bacteria has
been demonstrated in fetal sheep, signifying that early fetal
neutrophils are physiologically distinct from those present
at the end of gestation or postnatal cells [68]. Thus, there
are multiple facets to the much diminished inﬂammatory
response seen in scarlessly healing fetal wounds.
5.1. Growth Factor Proﬁles During Fetal Wound Healing.
The cytokine and growth factor proﬁle of fetal healing
diﬀers signiﬁcantly from adult wound healing. Many studies
have focused on TGF-β family members as these proteins
have been shown to have a major role in ﬁbrosis [69]. In
particular, the proﬁbrotic isoform TGF-β1h a sb e e nn o t e dt o
bereducedinearlyfetalwounds,andthishasbeenconﬁrmedDermatology Research and Practice 5
Table 1: Characteristic diﬀerences observed between fetal and adult wound healing.
Fetal Wound Healing Adult Wound Healing
Inﬂammation Minimal Robust
Select Growth Factors
PDGF Transient Sustained
FGF Low High
TGFβ Low TGFβ1 and TGFβ2H i g h T G F β1 and TGFβ2
High TGFβ3L o w T G F β3
Proinﬂammatory cytokines
IL-6 Low High
IL-8 Low High
Anti-inﬂammatory cytokine
IL-10 High Low
Formation of granulation tissue No Yes
ECM Proteins
Collagen Increased Type III collagen
(ratio of type III:type I is high)
Increased Type I collagen
(ratio of type I:type III is high)
Fibronectin Early Deposition Late Deposition
Tenascin Early Appearance Late Appearance
Proteoglycans and Glycosaminoglycans
Hyaluronic Acid High Low
Fibromodulin High Low
Decorin Low High
Myoﬁbroblasts No Yes
Integrins during re-epithelialization Early Late
CCT-subunits
CCT-eta Low High
CCT-beta No change No change
in incisional and excisional wounds in murine, rat, and
human skin [70–74]. Conversely, the anti-ﬁbrotic isoform
TGF-β3 is found in higher levels in scarlessly healing fetal
wounds [75]. In addition, TGF-β receptors TGF-βRI and
TGF-βRII are present at lower levels in fetal wounds than in
adult wounds. The relative scarcity of TGF-β1 is of particular
relevance, as multiple studies have demonstrated that the
addition of TGF-β1 causes scar to form in fetal skin wounds
that would otherwise heal scarlessly [70–72].
There are also diﬀerences in other growth factor groups.
Although PDGFs are initially present in both adult and fetal
wounds, they disappear more rapidly in the fetal wounds.
Additionally, administration of exogenous PDGF in fetal
rabbits induces ﬁbrosis, consistent with the notion that the
relative transience of PDGF in fetal wounds may also play
a crucial role in scarless wound healing [76]. Fibroblast
growth factor (FGF) family members were also found to
be diﬀerentially expressed in fetal skin both with advancing
gestational age and on wounding. FGF isoforms 1, 2, 5,
7, and 10 are increased in adult cutaneous wound healing,
but Dang et al. found that FGF isoforms 7 and 10 actually
decreased in scarlessly healing fetal wounds, while FGF
5 showed no change. There were also wound and age-
dependent changes in FGF receptor isoform levels, with the
authors concluding that overall there was diminished FGF
expression and signaling during scarless wound healing [77].
The role of vascular endothelial growth factor (VEGF) in
scarless fetal repair is not entirely clear. Some studies have
found that VEGF expression is reduced in scarless fetal
wounds compared to ﬁbrotic fetalwounds, and that addition
of exogenous VEGF to scarlessly healing wounds can induce
ﬁbrosis, suggesting that VEGF has additional importance to
wound healing beyond simply promoting angiogenesis [78].
However, Colwell et al. [79] found that VEGF mRNA levels
were higher in E16 scarless excisional rat wounds compared
to ﬁbrotic wounds at E18.
Interleukins have also been implicated in scarless wound
healing. It has been shown that the proinﬂammatory medi-
ators IL-6 and IL-8 are produced in low levels in both
fetal skin and in fetal-derived ﬁbroblasts when compared
to adult skin or adult-derived ﬁbroblasts [80]. Furthermore,
fetal skin deﬁcient in IL-10, widely considered to be an
anti-inﬂammatory agent, heals with a scar compared to
fetal skin with normal levels of IL-10, which heals scarlessly
[81]. Conversely, overexpression of IL-10 in adult wounds
decreases the inﬂammatory response and creates an envi-
ronment conducive for regenerative wound healing in adult
organisms [82, 83].6 Dermatology Research and Practice
Table 2: Observed diﬀerences between fetal and adult ﬁbroblasts.
Fetal Fibroblast Adult Fibroblast
alpha-SMA
(serum containing cultures) Low High
In-vitro collagen
contraction Less More
Hyaluronic acid
(HA)
Increased HA
synthesis
irrespective of cell
density
Decreased HA
synthesis
as cell density
increases
Hyaluronic acid
receptor High Low
Proinﬂammatory
cytokines
IL-6 Low High
IL-8 Low High
CCT-subunits
CCT-eta Low High
CCT-beta No change No change
As noted above, many growth factors and cytokines
appear to vary in their expression in fetal and adult wounds.
While each may be important, their overall signiﬁcance
may be obscured by the complexity of the cytokine mileu,
including other unknown or unexamined factors acting in
fetal and adult wound healing.
6. Fibroblasts and Myoﬁbroblasts in Fetal
Wound Healing
It has been speculated for many years that ﬁbroblasts are
the primary cell type responsible for determining whether
scarless or ﬁbrotic healing will occur (see Table 2); regen-
erative healing, after all, ultimately depends on the ability
of fetal ﬁbroblasts to produce and arrange new collagen
and other ECM components in similar quantities and
ratios to unwounded skin. Studies from Lorenz et al. [84]
indicated that fetal ﬁbroblasts were able to eﬀect scarless
healing even when transplanted to an adult environment.
Of particular note: no sign of ﬁbroblast conversion into
contractile myoﬁbroblasts has been observed at the stage
of fetal wound repair where scarless healing still obtains
[85]. Myoﬁbroblasts are found in late gestation fetal wounds,
where scar formation does occur after transition to an adult
healing pattern. Myoﬁbroblasts are also plentiful in adult
wound repair where they resemble smooth muscle cells,
and their characteristic expression of α-SMA mediates their
ability to exert a strong contractile force [86, 87].
One of the chief eﬀects of TGF-β on ﬁbroblastic cells is to
induce the expression of α-SMA and prompt conversion to
themyoﬁbroblastphenotype [88].Thiscanalsooccurinfetal
wounds, where the addition of exogenous TGF-β markedly
increases the abundance of myoﬁbroblastic cells while simul-
taneously inducing ﬁbrosis in an otherwise scarlessly healing
fetal milieu [89]. Our own investigations have conﬁrmed
that fetal ﬁbroblasts in culture express substantially lower
levels of α-SMA (even with serum stimulation) than do adult
ﬁbroblasts, whereas we ﬁnd no diﬀerence in total cellular β-
actin between fetal and adult cells [90]. These observations
collectively support the association of myoﬁbroblasts with
scar formation, and suggest that the lack of myoﬁbroblasts
typical of scarlessly healing fetal wounds is a critical compo-
nent thereof.
7. Keratinocytesand Re-Epithelializationin
Fetal WoundHealing
Much attention has been given to the chemistry and
biology of fetal dermal constituents, since that is where fetal
ﬁbroblasts reside. Relatively less attention has been paid to
the properties of fetal keratinocytes and the process of fetal
re-epithelialization, although it has been observed to occur
more rapidly in healing fetal wounds [91–94]. Martin and
his colleagues [85, 95] have focused much of their eﬀort on
fetal wound re-epithelialization and have identiﬁed funda-
mental diﬀerences in the mechanics of re-epithelialization
in embryonic wounds. Whereas adult wounds have been
shown to re-epithelialize through extension of lamellipodia
followed by epidermal cells at the wound edge crawling over
the wound bed [96], embryonic wounds exhibit no signs
of lamellipodia or ﬁlopodial extensions. Instead, epidermal
cells at the edge of wounds in both chick and mouse
embryos assemble an actin “cable” that functions like a
purse-string to close the wound [85, 95]. The importance
of this purse-string formation was shown by the addition of
cytochalasin D, which disrupted the assembly of the actin
cable and blocked wound re-epithelialization [96]. Studies
have also demonstrated the requirement for the small GTP-
binding protein Rho, but not Rac, in the proper assembly
of the actin cable and re-epithelialization of fetal wounds
[97]. The presence of actin cables (and the essential role
of the actin cytoskeleton) in re-epithelialization have been
conﬁrmed in fetal rat E17 wounds (at which point healing
is still scarless) but not in E19 wounds (at which point the
transitiontoadultwoundhealinghasalreadyoccurred)[98].
In addition, paxillin has been shown to colocalize with actin
in E17 wounds but not in E19 wounds, whereas gelsolin was
a s s o c i a t e dw i t ha c t i ni nE 1 9w o u n d sb u tn o tE 1 7w o u n d s
[98].
Another factor that has been implicated in the faster
re-epithelialization seen in fetal wounds is the more rapid
upregulation of integrins in response to wounding in fetal
keratinocytes versus adult keratinocytes. In human fetal
skin transplanted subcutaneously onto nude mice and
then wounded, increased expression of multiple integrins
recognizing collagen, ﬁbronectin, laminin, and tenascin was
evidentattheepidermaledgewithinfourhoursofwounding
and persisted until re-epithelialization was complete [99]. In
contrast,studiesonadultwoundsinaporcinemodelshowed
thatintegrinﬁbronectinreceptorswerenotupregulateduntil
5 days after wounding [100]. Two additional studies from
Zambruno et al. [101] and Juhasz et al. [102] showed that
integrin expression for collagen, ﬁbronectin and laminin
receptors was not upregulated until 48 hours after wounding
in healing 3-mm wounds in split-thickness adult humanDermatology Research and Practice 7
skin grafts transplanted onto nude mice. Thus, it appears
that similar integrins are stimulated in both fetal and adult
wounds but the timing at which they appear varies greatly.
Reports have also identiﬁed diﬀerences in the expression
patterns of the transcription factor c-fos and AP-1 in
epidermis during fetal wound healing [103]. These multiple
observations collectively show that the process of wound
re-epithelialization and the physiology of fetal keratinocytes
diﬀer substantially from adult wound healing biology.
8. ExpressomicEvaluationof Scarless
versusScarringWounds
In the above sections we have reviewed many of the gene
products found to display diﬀerential expression in fetal and
adult wound healing, focusing mostly on growth factors and
ECM constituents. However, multiple other genes have been
implicated in fetal skin development and scarless wound
healing. Colwell et al. [104] determined that mRNA levels of
lysyl oxidase, an enzyme that cross-links collagenand elastin,
were signiﬁcantly greater in E19 late-gestation wounds (that
heal with a scar) in comparison to E17 early-gestation
scarless wounds in mouse. The homeobox genes Msx-1,
Msx-2, and Mox-1 display altered expression with increasing
gestational age, with Mox-1 becoming undetectable in adult
skin tissues [105].
Recognizing that there remained thousands of gene
products that had not been directly assayed in healing fetal
wounds, investigators have begun applying more compre-
hensive transcriptomic techniques to the study of scarless
wound healing. Several laboratories have used microarray
as a tool to identify expressomic diﬀerences during scarless
repair. Chen et al. [106] used a 5,705 oligonucleotide array to
examine early gestational (scarless) rat skin versus late gesta-
tional (scarring) skin. They found 53 diﬀerentially expressed
genes, and directly conﬁrmed by RT-PCR and Western blot
thatFGF8andfollistatinhadstrongerexpressioninearlyges-
tational skin compared to late, whereas lymphoid enhancer
bindingfactor-1andbeta-cateninshowedweakerexpression.
Colwell et al. [107] showed that the scarlessly healing fetal
skin wound transcriptome has rapid upregulation of many
genes from 1 to 24 hrs, but that by 24 hrs many fetal wound-
elevated gene expression levels had already begun to reverse
to baseline. They suggest that numerous gene products are
involved in coordinating the regenerative pattern of healing
found in early fetal wounds. Recent studies by Antony et al.
[108] show rapid upregulation of neurodevelopmental genes
during scarless repair on after injury days 1–3. The authors
speculate that these factors may promote the survival and
regeneration of peripheral neurons, which may promote a
scarless pattern of repair in response to injury.
Our own laboratory has used multiple expressomic
techniquestoexaminethetranscriptomeofscarlesslyhealing
fetal wounds, including diﬀerential display [109], PCR sup-
pression subtraction hybridization (PCR-SSH) [110], and
fetal wound-speciﬁc microarrays. Each of these techniques
allows an interrogation of the fetal wound expressome
without any preconceptions as to which gene products may
be important. Using PCR-SSH we have identiﬁed multiple
candidate genes and expressed sequence tags (ESTs) to be
diﬀerentially expressed in healing fetal wounds, and also
fragments of genes with no clear match in the GenBank
database, suggesting that the relevant gene set to scar-
less fetal wound healing may be larger than anticipated
[110]. Using rabbit fetal wound-speciﬁc microarrays that
we ourselves constructed from a cDNA library, we found
that some 20% of the recovered cDNA sequence fragments
demonstrated either no homology to GenBank sequences or
had such limited homology that we could not conﬁdently
identify a known cognate gene (Kathju et al., manuscript in
preparation). While some of these putative unknown gene
products may well turn out to be species-speciﬁc variations
of actual known genes, we have also obtained full length
clonesofseveralpreviouslyuncharacterizedsequences,again
suggesting that the determinative fetal wound gene set
includes novel factors.
Assay of the scarless wound transcriptome by diﬀerential
displayinourlabidentiﬁedtheetasubunitofthechaperonin
containing T-complex polypeptide (CCT-eta) as a gene
product speciﬁcally downregulated in fetal wound healing.
We have subsequently shown that this pattern of expression
is not shared by any other CCT subunit (of which there are
eight), and that CCT-eta is less abundant in fetal ﬁbroblasts
than in adult cells [90, 111]W eh a v ea l s od e m o n s t r a t e d
that CCT-eta is a speciﬁc regulator of ﬁbroblast motility and
contractility, with siRNA-mediated reduction of CCT-eta
inhibitingtheabilityofadultﬁbroblaststorespondtomigra-
tory and contractile stimuli, rendering them more “fetal-
like” in their behavior, possibly by secondary inhibition of α-
SMA protein expression. This observation suggests that gene
products that control ﬁbroblast motility and contractility
may be especially relevant to distinguishing scarless from
ﬁbrotic wound healing [90].
9.FuturePerspectives
Through the past 50 years, studies have been directed
towards explicating the remarkable ability of mammalian
fetuses to heal cutaneous wounds by regeneration, but we
are still far from a complete understanding of the critical
molecular determinants of this phenomenon. Although
much has been learned, there remain numerous unexplored
questions about the relative biology of fetal wounds versus
their scirrhous adult counterparts. The role of nitric oxide,
increasinglythoughttobeimportanttoadultwoundhealing,
is still largely a mystery in fetal wounds. The role of
microRNAs, now also emerging as important players in
adult wound healing [112] similarly remains unexplored.
Ultimately, a fuller appreciation of the most important
factors governing the scarless pattern of fetal wound repair
will hopefully allow for intervention in the adult wound
healing milieu to mitigate scar formation and improve the
clinical outcome of those aﬄicted with the morbidity of scar.
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